⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
WOCKPHARMA - Technical Analysis with Chart Patterns & Indicators
Last Updated Time : 05 Nov 25, 7:43 am
Back to Technical ListTechnical Rating: 3.0
📉 WOCKPHARMA is currently in a reversal phase with bearish momentum and weak technical indicators. Entry zone: ₹1,200–₹1,281; exit zone: ₹1,350–₹1,420. Watch for RSI recovery and MACD flattening to confirm bottoming out.
📊 Technical Overview
- Price Action: Trading at ₹1,281, below both 50-DMA (₹1,426) and 200-DMA (₹1,412), indicating short- and medium-term weakness.
- RSI (33.6): Near oversold zone, suggesting potential for technical bounce but no confirmation yet.
- MACD (-46.7): Bearish crossover, confirming downward pressure.
- Bollinger Bands: Price near lower band, indicating oversold conditions with possible support.
- Volume: Below 1-week average, showing weak participation and low conviction.
- Support Zones: ₹1,200 (S1), ₹1,110 (S2)
- Resistance Zones: ₹1,350 (R1), ₹1,420 (R2)
✅ Positive
- Quarterly PAT increased from ₹40 Cr. to ₹69 Cr., a 1,050% jump.
- EPS of ₹3.01 reflects earnings recovery.
- Price has rebounded ~15% from its 52-week low of ₹1,110.
⚠️ Limitation
- Stock P/E (408) is extremely high compared to industry average (33.1), indicating severe overvaluation.
- PEG ratio of 16.9 suggests poor earnings growth relative to valuation.
- ROCE (4.40%) and ROE (-0.53%) reflect weak capital efficiency.
- Price trading well below key moving averages confirms bearish bias.
📉 Company Negative News
- FII holdings declined (-0.19%), reflecting reduced foreign investor confidence.
- Price has corrected ~31% from its 52-week high of ₹1,870.
📈 Company Positive News
- Quarterly profit surge signals operational turnaround.
- MACD and RSI nearing reversal zones, suggesting potential bottoming out.
🏢 Industry
- Pharmaceutical sector benefits from global healthcare demand and innovation in specialty drugs.
- Industry P/E of 33.1 reflects moderate valuation across peers.
🧭 Conclusion
- WOCKPHARMA is in a reversal phase with weak technical indicators and improving fundamentals.
- Entry zone: ₹1,200–₹1,281; exit zone: ₹1,350–₹1,420 for short-term bounce trades.
- Long-term investors should wait for trend reversal confirmation and earnings consistency before accumulating.
NIFTY 50 - Today Top Technical Picks Stock Picks
NEXT 50 - Today Top Technical Picks Stock Picks
MIDCAP - Today Top Technical Picks Stock Picks
SMALLCAP - Today Top Technical Picks Stock Picks